[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011,61(2): 69-90.
[2] Maghfoor I, Perry MC. Lung cancer[J]. Ann Saudi Med, 2005,25(1):1-12.
[3] Hanna N, Neubauer M, yiannoutsos C, et al. Phase Ⅲ study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage Ⅲ non-small-cell lung cancer: the Hoosier Oncology Group and US Oncology[J]. J Clin Oncol, 2008, 26(35): 5755-5760.
[4] Messerschmidt DM, de Vries W, Ito M, et al. Trim28 is required for epigenetic stability during mouse oocyte to embryo transition[J]. Science, 2012, 335(6075): 1499-1502.
[5] Barde I, Rauwel B, Marin-Florez RM, et al. A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy[J]. Science, 2013, 340(6130): 350-353.
[6] Pfeifer GP. Protein phosphatase PP4: Role in dephosphorylation of KAP1 and DNA strand break repair[J]. Cell Cycle, 2012, 11(14): 2590-2591.
[7] White DE, Negorev D, Peng H, et al. KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions[J]. Cancer Res, 2006, 66(24): 11594-11599.
[8] Gilmore-Hebert M, Ramabhadran R, Stern DF. Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways[J]. Mol Cancer Res, 2010, 8(10): 1388-1398.
[9] Hu C, Zhang S, Gao X, et al. Roles of Kruppel-associated box (KRAB)-associated co-repressor KAP1 Ser-473 phosphorylation in DNA damage response[J]. J Biol Chem, 2012, 287(23): 18937-18952.
[10] Lin LF, Li CF, Wang WJ, et al. Loss of ZBRK1 contributes to the increase of KAP1 and promotes KAP1-mediated metastasis and invasion in cervical cancer[J]. PLoS One, 2013, 8(8): e73033.
[11] Addison JB, Koontz C, Fugett JH, et al. KAP1 promotes proliferation and metastatic progression of breast cancer cells[J]. Cancer Res, 2015, 75(2): 344-355.
[12] Fitzgerald S, Sheehan KM, O’grady A, et al. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients[J]. J Gastroenterol Hepatol, 2013, 28(6): 967-974.
[13] Yokoe T, Toiyama Y, Okugawa Y, et al. KAP1 is associated with peritoneal carcinomatosis in gastric cancer[J]. Ann Surg Oncol, 2010, 17(3): 821-828.
[14] Zhang L, Zhu C, Guo Y, et al. Inhibition of KAP1 enhances hypoxia-induced Kaposi’s sarcoma-associated herpesvirus reactivation through RBP-Jκ[J]. J Virol, 2014, 88(12): 6873-6884.
[15] Liu L, Zhao E, Li C, et al. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer[J]. Cancer Epidemiol, 2013, 37(1): 71-78.
[16] Wang C, Rauscher FJ 3rd, Cress WD et al. Regulation of E2F1 function by the nuclear corepressor KAP1[J]. J Biol Chem, 2007, 282(41): 29902-29909.
[17] Meng RD, Phillips P, El-Deiry WS. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin[J]. Int J Oncol, 1999, 14(1): 5-14.
[18] White D, Rafalska-Metcalf IU, Ivanov AV, et al. The ATM substrate KAP1 controls DNA repair in heterochromatin: Regulation by HP1 proteins and serine 473/824 phosphorylation[J]. Mol Cancer Res, 2012, 10(3): 401-414.
[19] Wang C, Ivanov A, Chen L, et al. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation[J]. EMBO J, 2005, 24(18): 3279-3290.
[20] Kamitani S, Ohbayashi N, Ikeda O, et al. KAP1 regulates type I interferon/STAT1-mediated IRF-1 gene expression[J]. Biochem Biophys Res Commun, 2008, 370(2): 366-370.
[21] Huang C, Martin S, Pfleger C, et al. Cutting edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28[J]. J Immunol,2013, 190(9): 4470-4473.
[22] Nip J, Strom DK, Fee BE, et al. E2F-1 cooperates with topoisomerase Ⅱ inhibition and DNA damage to selectively augment p53-independent apoptosis[J]. Mol Cell Biol, 1997, 17(3): 1049-1056.
[23] Dong YB, Yang HL, Elliott MJ, et al. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase Ⅱ inhibitors[J]. Cancer Res, 2002, 62(6): 1776-1783.
[24] Okamoto K, Kitabayashi I, Taya Y. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction[J]. Biochem Biophys Res Commun, 2006, 351(1): 216-222.
|